rs147700427
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_153006.3(NAGS):c.1368C>G(p.Ser456=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00272 in 1,604,718 control chromosomes in the GnomAD database, including 13 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. S456S) has been classified as Likely benign.
Frequency
Consequence
NM_153006.3 synonymous
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -21 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
NAGS | NM_153006.3 | c.1368C>G | p.Ser456= | synonymous_variant | 6/7 | ENST00000293404.8 | |
NAGS | XM_011524439.2 | c.870C>G | p.Ser290= | synonymous_variant | 6/7 | ||
NAGS | XM_011524438.2 | c.1268+196C>G | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
NAGS | ENST00000293404.8 | c.1368C>G | p.Ser456= | synonymous_variant | 6/7 | 1 | NM_153006.3 | P1 | |
NAGS | ENST00000589767.1 | c.1299C>G | p.Ser433= | synonymous_variant | 6/7 | 2 | |||
NAGS | ENST00000592915.1 | n.1256C>G | non_coding_transcript_exon_variant | 3/4 | 2 |
Frequencies
GnomAD3 genomes ? AF: 0.00182 AC: 277AN: 152178Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00170 AC: 393AN: 231746Hom.: 3 AF XY: 0.00164 AC XY: 206AN XY: 125602
GnomAD4 exome AF: 0.00282 AC: 4090AN: 1452422Hom.: 13 Cov.: 30 AF XY: 0.00271 AC XY: 1955AN XY: 721544
GnomAD4 genome ? AF: 0.00182 AC: 277AN: 152296Hom.: 0 Cov.: 32 AF XY: 0.00162 AC XY: 121AN XY: 74468
ClinVar
Submissions by phenotype
Hyperammonemia, type III Benign:3
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 27, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. - |
Benign, no assertion criteria provided | clinical testing | Natera, Inc. | Dec 05, 2019 | - - |
Benign, criteria provided, single submitter | clinical testing | Invitae | Jan 31, 2024 | - - |
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | May 25, 2018 | - - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Mar 01, 2024 | NAGS: BP4, BP7, BS2 - |
NAGS-related disorder Benign:1
Likely benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Nov 22, 2019 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at